Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventions for Cardiovascular Disease: "Real-World" Effectiveness of Combined Pharmacotherapy and Behavioural Counseling for Smoking Cessation

NCT01623505 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT01623505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01623505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventions for Cardiovascular Disease: "Real-World" Effectiveness of Combined Pharmacotherapy and Behavioural Counseling for Smoking Cessation
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2014
Enrollment
738 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychiatric illness, smoking cessation